Org.nr 816 690 242 2023 → 2024 Year-over-year analysis

ABEL HEALTH AS: årsregnskap 2024 vs 2023

Grew 632% on revenue, stronger earnings

approved 2025-06-24; registry 2025-07-09; journal 2025 651457

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2024 with 2023 for ABEL HEALTH AS. Revenue 9.33m NOK → 68.30m NOK (+631.8%). Net result +317.7k NOK → +13.45m NOK. Equity 218.7k NOK → 197.8k NOK.

On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: equity eroded.

Also worth watching: thin equity buffer; payroll increased; cogs moved. All figures are taken from the published annual accounts for ABEL HEALTH AS.

Scorecard

Revenue
9.33m NOK 68.30m NOK
+631.8%
Operating result
+599.5k NOK +17.08m NOK
+2748.3%
Net result
+317.7k NOK +13.45m NOK
+4134.1%
Equity
218.7k NOK 197.8k NOK
-9.6%
Cash
615.5k NOK 662.5k NOK
+7.6%
Total assets
2.75m NOK 22.82m NOK
+731.2%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 9.33m NOK to 68.30m NOK (+631.8% YoY). Calculated

  • ↑

    Operating result improved

    Operating result +599.5k NOK → +17.08m NOK (op. margin 6.4% → 25.0%). Calculated

  • ↑

    Net result improved

    Net result +317.7k NOK → +13.45m NOK (net margin 3.4% → 19.7%). Calculated

  • ↑

    Cash rose

    Bank deposits 615.5k NOK → 662.5k NOK (+7.6% YoY). Calculated

What deteriorated

  • ↓

    Equity eroded

    Book equity 218.7k NOK → 197.8k NOK (equity ratio 8.0% → 0.9%). Calculated

Things to notice

  • ·

    Thin equity buffer

    Equity ratio is 0.9% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation

  • ·

    Payroll increased

    Salary cost 1.72m NOK → 9.48m NOK (18% → 14% of revenue). Calculated

  • ·

    COGS moved

    COGS / varekostnad 7.36m NOK → 39.80m NOK (+440.7% YoY). Calculated

  • ·

    Book investments changed

    Investment / intangible book value 500.0k NOK → 1 NOK. Reported fact